RWE Expert Discusses Ripple Effects of FDA Framework Throughout Pharma
In a recent interview, Roche’s Global Head of Real World Evidence (RWE) and Market Access Sreeram Ramagopalan shared his thoughts [...]
Kaiser Family Foundation Executive Discusses Medicare Drug Pricing Legislation
Executive Vice President for Health Policy at the Kaiser Family Foundation Larry Levitt shared his thoughts on the Congressional Budget [...]
PhRMA’s 2021 Biopharmaceutical Industry Profile Now Available
PhRMA has published this year’s Biopharmaceutical Profile. The report highlights key industry trends, such as prescription drug pricing policy measures, [...]
Public Health and Pharmacy Professor Reviews Recent Publication on Drug Misuse in Healthcare
University of Arizona Professor and Dean Emeritus at the University of Kansas School of Pharmacy Jack Fincham, PhD discussed a [...]
2021’s PBMI Conference Featured Lively Discussions on Specialty Drug Costs, Data Interoperability, and RWD
The Pharmacy Benefit Management Institute (PBMI) recently held its annual conference. This year, the hybrid format allowed for lively discussions [...]
ICER Whitepaper Proposes Improvements to the FDA’s Accelerated Approval Pathway
The Institute for Clinical and Economic Review (ICER) has released a whitepaper proposing policy reforms that would improve the Food and Drug [...]
BMJ Article Questions the Use of Surrogate Endpoints in Drug Assessments
An article published in the British Medical Journal (BMJ) details the controversial use of surrogate endpoints in assessing a drug’s [...]
On-Demand Webinar on Unmet Need in Oncology Healthcare
BioPlus Specialty Pharmacy is offering an on-demand webinar featuring EVP and Oncology Practice Head at Cello Health BioConsulting Jeff Bockman, Ph.D. [...]
ICER’s Draft Evidence for Hypertrophic Cardiomyopathy Drug Now Available
The Institute for Clinical and Economic Review (ICER) has released its draft evidence report for mavacamten, a drug intended for use [...]
RWE Informs Decision-Making for Vaccines, Digital Therapeutics, and Medications
Real world evidence (RWE) is increasingly used in healthcare and pharma decision-making. A recent article explores its use in addressing [...]
Pharma and Healthcare Turn to Creative Communications to Improve Patient Outcomes
A growing number of organizations are recognizing the power of creative communications in conveying a medical product’s advantages or in [...]
Syneos Health Announces Acquisition of StudyKIK
Syneos Health has announced its acquisition of clinical trial solution company StudyKIK. The acquisition will bolster clinical trial recruitment efforts, [...]
OptumRx Strikes Deal With Point32Health for PBM Solutions
OptumRx has reached an agreement with the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, Point32Health. Pharmacy [...]
What is the Specialty Drug Commercialization Pipeline?
Specialty drugs are high cost pharmaceutical products intended for a small number of patients. The specialty drug commercialization process requires [...]
Biogen CEO Discusses Tumultuous Aduhelm Launch
Biogen CEO Michel Vounatsos recently shared his thoughts regarding the hectic Aduhelm launch at the Morgan Stanley 19th Annual Global [...]
ISPOR Article on Prescription Drug Price Variation in Last Decade
In a recent article published in Value in Health, the authors investigate pharmaceutical drug prices. They note significant variation among payers; [...]
MAPS Webinar Features Authors of Recent MSL Position Statement
The Medical Affairs Professional Society (MAPS) is offering an on-demand webinar featuring insight from the authors of a recently published [...]
Vesto and Oldham Global Collaborate to Offer Financing for High Cost Therapies
Crypto company Vesto and development company Oldham Global have announced a partnership to provide financing for expensive pharmaceuticals. Payers and [...]
AMCP’s Fundamentals of Managed Care Pharmacy Certificate Program Now Available
The Fundamentals of Managed Care Pharmacy Certificate Program, offered by the Academy of Managed Care Pharmacy (AMCP), is now available. [...]
Democrats’ Success in Drug Pricing Legislation Hinges on Select Group of Individuals
Democrats are attempting to lower drug prices through legislation. Ten individuals could determine the initiative’s outcome. “The effort’s success depends [...]
Congressional Budget Office’s Updated Model Predicts Impact of Pricing Legislation on Pharma Innovation
The Congressional Budget Office (CBO) released an updated model intended to predict how drug pricing bills, including Medicare negotiation, would [...]
Economists and Policy Experts Discuss Six Strategies to Address High Drug Costs
Paul Ginsberg and Steven Lieberman of the USC-Brookings Schaeffer Initiative for Health Policy discuss six policies that could address the [...]
Merck and Amgen Boldly Test the Limits of Prescription Drug Price Increases
Pharmaceutical companies generally keep drug prices increases around 5% per year. This year, Merck and Amgen tested that unofficial limit. [...]
Infographic Features Insight on Payers Throughout Drug Development Process
An infographic offered by Cyan Health provides insight into payer perceptions throughout drug development. Understanding the points at which payers [...]
Read the New Certara Blog Post on Succeeding in Value Communication
Certara’s Senior Digital Marketing Executive Tom Hemy discusses the steps that make up successful value communication. Rather than using spreadsheets [...]